HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yugo Isobe Selected Research

1,2- dipalmitoyl- 3- phosphatidylethanolamine

2/2018Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yugo Isobe Research Topics

Disease

1Neoplasm Metastasis (Metastasis)
02/2018
1Neoplasms (Cancer)
02/2018
1Rheumatoid Arthritis
09/2017
1Osteoporosis
09/2017
1Bone Diseases (Bone Disease)
09/2017

Drug/Important Bio-Agent (IBA)

2Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
02/2018 - 09/2017
1tesmilifene (DPPE)IBA
02/2018
11,2- dipalmitoyl- 3- phosphatidylethanolamineIBA
02/2018
1Aspartic Acid (Aspartate)FDA Link
02/2018
1Liposomes (Liposome)IBA
02/2018
1Paclitaxel (Taxol)FDA LinkGeneric
02/2018
1isothiocyanic acidIBA
09/2017
1Dendrimers (Dendrons)IBA
09/2017
1Durapatite (Hydroxylapatite)IBA
09/2017
1Fluorescein (Funduscein)FDA LinkGeneric
09/2017
1PAMAM StarburstIBA
09/2017
1Poly(amidoamine)IBA
09/2017
1Carboxylic AcidsIBA
09/2017

Therapy/Procedure

1Intravenous Injections
02/2018